BSX vs GBCI · P/E 20, rev $10.65B vs P/E 23, rev $55.0M
Boston Scientific Corp (BSX) versus Glacier Bancorp Inc (GBCI) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Glacier Bancorp Inc (GBCI) is a banks - regional company listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported GBCI revenue for 2026-06-30 was $55.0M. Net income was $180.0M. GBCI currently screens at market cap $6.27B and trailing P/E 22.5.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. GBCI currently screens at market cap $6.27B and trailing P/E 22.5.
Not investment advice. Open the BSX and GBCI stock pages for the full models.
Not investment advice.